| Name | 6-chloro-4-N-cyclopentylpyrimidine-4,5-diamine |
|---|---|
| Synonyms |
F2124-0091
6-chloro-N4-cyclopentyl-pyrimidine-4,5-diyldiamine 6-chloro-n4-cyclopentylpyrimidine-4,5-diamine 6-Chlor-N4-cyclopentyl-pyrimidin-4,5-diyldiamin |
| Density | 1.378g/cm3 |
|---|---|
| Boiling Point | 388.9ºC at 760 mmHg |
| Molecular Formula | C9H13ClN4 |
| Molecular Weight | 212.67900 |
| Flash Point | 189ºC |
| Exact Mass | 212.08300 |
| PSA | 63.83000 |
| LogP | 2.72090 |
| Index of Refraction | 1.669 |
| HS Code | 2933599090 |
|---|
|
~77%
5452-43-7 |
| Literature: Burroughs Wellcome Co. Patent: US5039689 A1, 1991 ; |
|
~77%
5452-43-7 |
| Literature: Kelley, James L.; Morris Bullock; Krochmal, Mark P.; McLean, Ed W.; Linn, James A.; Durcan, Micheal J.; Cooper, Barrett R. Journal of Medicinal Chemistry, 1997 , vol. 40, # 20 p. 3207 - 3216 |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |